European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing
- PMID: 23012123
- DOI: 10.1055/s-0032-1309791
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing
Abstract
Multidisciplinary, evidence-based guidelines for quality assurance in colorectal cancer screening and diagnosis have been developed by experts in a project coordinated by the International Agency for Research on Cancer. The full guideline document covers the entire process of population-based screening. It consists of 10 chapters and over 250 recommendations, graded according to the strength of the recommendation and the supporting evidence. The 450-page guidelines and the extensive evidence base have been published by the European Commission. The chapter on faecal occult blood testing includes 21 graded recommendations. The content of the chapter is presented here to promote international discussion and collaboration by making the principles and standards recommended in the new EU Guidelines known to a wider professional and scientific community. Following these recommendations has the potential to enhance the control of colorectal cancer through improvement in the quality and effectiveness of screening programmes and services.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary.Endoscopy. 2012 Sep;44 Suppl 3:SE1-8. doi: 10.1055/s-0032-1309822. Epub 2012 Sep 25. Endoscopy. 2012. PMID: 23012113
-
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Evaluation and interpretation of screening outcomes.Endoscopy. 2012 Sep;44 Suppl 3:SE49-64. doi: 10.1055/s-0032-1309788. Epub 2012 Sep 25. Endoscopy. 2012. PMID: 23012122
-
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Introduction.Endoscopy. 2012 Sep;44 Suppl 3:SE15-30. doi: 10.1055/s-0032-1308898. Epub 2012 Sep 25. Endoscopy. 2012. PMID: 23012118
-
Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations.Virchows Arch. 2011 Jan;458(1):1-19. doi: 10.1007/s00428-010-0977-6. Virchows Arch. 2011. PMID: 21061133 Free PMC article. Review.
-
Performance improvements of stool-based screening tests.Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):479-92. doi: 10.1016/j.bpg.2010.03.009. Best Pract Res Clin Gastroenterol. 2010. PMID: 20833351 Review.
Cited by
-
Tests detecting biomarkers for screening of colorectal cancer: What is on the horizon?GMS Health Technol Assess. 2015 Jun 10;11:Doc01. doi: 10.3205/hta000122. eCollection 2015. GMS Health Technol Assess. 2015. PMID: 26131022 Free PMC article.
-
Comparison of patient preferences for fecal immunochemical test or colonoscopy using the analytic hierarchy process.BMC Health Serv Res. 2015 Apr 23;15:175. doi: 10.1186/s12913-015-0841-0. BMC Health Serv Res. 2015. PMID: 25902770 Free PMC article.
-
Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer.Int J Mol Sci. 2023 Jun 23;24(13):10520. doi: 10.3390/ijms241310520. Int J Mol Sci. 2023. PMID: 37445698 Free PMC article. Review.
-
A Novel Urinary miRNA Biomarker for Early Detection of Colorectal Cancer.Cancers (Basel). 2022 Jan 17;14(2):461. doi: 10.3390/cancers14020461. Cancers (Basel). 2022. PMID: 35053622 Free PMC article.
-
Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?Cancers (Basel). 2019 Jan 20;11(1):120. doi: 10.3390/cancers11010120. Cancers (Basel). 2019. PMID: 30669538 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical